Clinical Trials Browser

Phase 1 × Triple Negative Breast Neoplasms × Granulocyte Colony-Stimulating Factor × Clear all

NCT04584112 2023-03-15

A Study of the Safety, Efficacy, and Pharmacokinetics of Tiragolumab in Combination With Atezolizumab and Chemotherapy in Participants With Triple-Negative Breast Cancer

Phase 1 Completed

Triple Negative Breast Neoplasms